Partner, Orlando Physician Specialists, at the Winter Park Cancer Center

Radiation Oncology

Dr. Jamie A. Cesaretti, MD

Jamie A. Cesaretti is an expert in the field of Radiation Oncology. He went to Mount Sinai School of Medicine. Dr. Jamie A. Cesaretti is a published doctor and has 45 publications published. The lastest was: 'Salvage brachytherapy for recurrent prostate cancer.'

Publications

Salvage brachytherapy for recurrent prostate Cancer.
A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following Radiation therapy for...
Long-term outcomes and prognostic factors in patients treated with intraoperatively planned Prostate brachytherapy.
Radiotherapy Planning Complexity and Survival after Treatment of Advanced Stage Lung Cancer in the Elderly.
Update on Prostate brachytherapy: long-term outcomes and treatment-related morbidity.
Erratum: Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases.
Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate Cancer.
Do high radiation doses in locally advanced prostate Cancer patients treated with 103Pd implant plus external beam irradiation cause increased urinary, rectal, and sex...
Local control following permanent Prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes.
Does neoadjuvant hormonal therapy improve urinary function when given to men with large Prostates undergoing Prostate brachytherapy?
Radiation dose predicts for biochemical control in intermediate-risk prostate Cancer patients treated with low-dose-rate brachytherapy.
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary...
Prognostic significance of 5-year PSA value for predicting prostate Cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam...
There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate Prostate brachytherapy.
Distant and local recurrence in patients with biochemical failure after Prostate brachytherapy.
Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for pros...
TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate Cancer patients treated with radiotherapy.
Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
(125)I monotherapy using D90 implant doses of 180 Gy or greater.
Possession of ATM sequence variants as predictor for late normal tissue responses in breast Cancer patients treated with radiotherapy.
Brachytherapy for the treatment of prostate Cancer.
A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with Prostate brachytherapy.
Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam ...
Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS.
Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function.
Low-dose rate Prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease.
Changing the patterns of failure for high-risk prostate Cancer patients by optimizing local control.
Genetic predictors of adverse radiotherapy effects: the Gene-PARE project.
Disease-specific survival following the brachytherapy management of prostate Cancer.
ATM sequence variants and risk of Radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy.
Biologically effective dose values for Prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.
ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate Cancer.
Does prior transurethral resection of Prostate compromise brachytherapy quality: a dosimetric analysis.
Combined modality treatment in the management of high-risk prostate Cancer.
Urinary symptom flare following I-125 Prostate brachytherapy.
Prostate-specific antigen bounce after prostate seed implantation for localized prostate Cancer: descriptions and implications.
Outcomes for patients with high-grade prostate Cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy.
Stereotactic radiosurgery for thoracic malignancies.
Effect of low dose-rate Prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-up.
Adjuvant Radiation with modern techniques is the standard of care for stage III thymoma.
Urinary symptom flare after brachytherapy for prostate Cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
Acceptability and preliminary feasibility of an internet/CD-ROM-based education and decision program for early-stage prostate Cancer patients: randomized pilot study.
Effect of Radiotherapy Planning Complexity on Survival of Elderly Patients with Unresected Localized Lung Cancer.
Urinary morbidity and incontinence following transurethral resection of the Prostate after brachytherapy.

Schools

State University Of New York At Stony Brook
Mt Sinai School Of Med
Columbia University
Mount Sinai School of Medicine

Procedures Preformed

Brachytherapy
Prostate Radioactive Seed Implants
Radiation Therapy
Stereotactic Radiosurgery

Conditions Treated

Brain Cancer
Breast Cancer
Laryngeal Cancer
Lung Cancer
View All

Doctors Specialties

Radiation Oncology

Accepted Insurances

Education

Mount Sinai School of Medicine
St Luke's-Roosevelt Hospital Center
Stony Brook University School of Medicine
Columbia University

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1669444725
Last Name Of The Provider	CESARETTI
First Name Of The Provider	JAMIE
View All

Similar Doctors

	Dr. Niraj H. Pahlajani, MD This Doctor is OpenDoctor Recommended.
	Dr. Mitchell D. Terk, MD This Doctor is OpenDoctor Recommended.
	Dr. Rizwan Nurani, MD This Doctor is OpenDoctor Recommended.
	Dr. Paul B. Ossi, MD This Doctor is OpenDoctor Recommended.
	Dr. Stephen Ko, MD This Doctor is OpenDoctor Recommended.
	Dr. Cynthia S. Anderson, MD This Doctor is OpenDoctor Recommended.
	Dr. Sonja L. Schoeppel, MD This Doctor is OpenDoctor Recommended.
	Dr. Ramesh Vedula, MD This Doctor is OpenDoctor Recommended.
	Dr. Laura A. Vallow, MD This Doctor is OpenDoctor Recommended.
	Dr. Julie A. Bradley, MD This Doctor is OpenDoctor Recommended.
	Dr. Corey J. Hobbs, MD This Doctor is OpenDoctor Recommended.
	Dr. Katherine S. Tzou, MD This Doctor is OpenDoctor Recommended.